We are the business consultancy for Latin America of the EsophyX technology, which is an innovative medical device for the treatment of chronic gastroesophageal reflux disease (GERD).

The approach, called Transoral Fundoplication without incision (TIF) has the potential
to treat patients who do not benefit from the daily medication known as
proton pump inhibitors (PPIs).

​

The TIF procedure recreates the anti-reflux barrier between the esophagus and the
stomach and is performed via transoral (traditional therapeutic endoscopy).
​
EndoGastric Solutions (EGS) is the leader in transoral technology used in

procedural therapy for GERD. EGS is dedicated to providing effective

solutions for healthcare professionals with patients who fall within the

growing spectrum  of chronic GERD sufferers whose needs are not

adequately addressed by the treatment options available today.